v3.26.1
Consolidated Statements of Earnings/(Loss) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]      
Revenue $ 254,248 $ 222,578 $ 226,827
Cost of products sold 244,474 214,410 219,413
Gross margin 9,774 8,168 7,414
Operating expenses:      
Distribution, selling, general, and administrative expenses 6,132 5,382 5,000
Restructuring and employee severance 106 88 175
Amortization and other acquisition-related costs 469 464 284
Acquisition-related cash and share-based compensation costs [Line Items] 287 126 0
Impairments and (gain)/loss on disposal of assets, net 177 18 634
Litigation (recoveries)/charges, net (10) (185) 78
Operating earnings 2,613 2,275 1,243
Other (income)/expense, net (31) (41) (9)
Interest expense, net 348 215 51
Equity Method Investment, Other-than-Temporary Impairment 122 0 0
Earnings before income taxes 2,174 2,101 1,201
Income Tax Expense (Benefit) 469 532 348
Net earnings 1,705 1,569 853
Less: Net (earnings)/loss attributable to noncontrolling interests 9 (8) (1)
Net earnings attributable to Cardinal Health, Inc. $ 1,714 $ 1,561 $ 852
Earnings per common share attributable to Cardinal Health, Inc.      
Basic (in dollars per share) $ 7.27 $ 6.48 $ 3.48
Diluted (in dollars per share) $ 7.23 $ 6.45 $ 3.45
Weighted-average number of common shares outstanding:      
Basic (in shares) 236 241 245
Diluted (in shares) 237 242 247